Order Article Reprints

Godman B, Shrank W, Wettermark B, Andersen M, Bishop I, Burkhardt T, Garuolienè K, Kalaba M, Laius O, Joppi R, et al. Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? Pharmaceuticals. 2010; 3(8):2470-2494. https://doi.org/10.3390/ph3082470

Godman, Brian, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt, Kristina Garuolienè, Marija Kalaba, Ott Laius, Roberta Joppi, and et al. 2010. "Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?" Pharmaceuticals 3, no. 8: 2470-2494. https://doi.org/10.3390/ph3082470

Godman, B., Shrank, W., Wettermark, B., Andersen, M., Bishop, I., Burkhardt, T., Garuolienè, K., Kalaba, M., Laius, O., Joppi, R., Sermet, C., Schwabe, U., Teixeira, I., Tulunay, F. C., Wendykowska, K., Zara, C., & Gustafsson, L. L. (2010). Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? Pharmaceuticals, 3(8), 2470-2494. https://doi.org/10.3390/ph3082470